FibroGen (FGEN) Misses Q1 EPS by 26c

May 12, 2015 7:03 AM EDT

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.78), $0.26 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $16.3 million versus the consensus estimate of $34 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities